Market Still Lacking Some Conviction On Al-Dawaa Medical Services Company (TADAWUL:4163)

When close to half the companies in Saudi Arabia have price-to-earnings ratios (or "P/E's") above 26x, you may consider Al-Dawaa Medical Services Company (TADAWUL:4163) as an attractive investment with its 22.2x P/E ratio. Although, it's not wise to just take the P/E at face value as there may be an explanation why it's limited.

Al-Dawaa Medical Services certainly has been doing a good job lately as it's been growing earnings more than most other companies. It might be that many expect the strong earnings performance to degrade substantially, which has repressed the P/E. If not, then existing shareholders have reason to be quite optimistic about the future direction of the share price.

Check out our latest analysis for Al-Dawaa Medical Services

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Al-Dawaa Medical Services.

How Is Al-Dawaa Medical Services' Growth Trending?

In order to justify its P/E ratio, Al-Dawaa Medical Services would need to produce sluggish growth that's trailing the market.

Retrospectively, the last year delivered an exceptional 18% gain to the company's bottom line. The strong recent performance means it was also able to grow EPS by 46% in total over the last three years. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

Turning to the outlook, the next three years should generate growth of 14% per year as estimated by the five analysts watching the company. With the market predicted to deliver 14% growth each year, the company is positioned for a comparable earnings result.

With this information, we find it odd that Al-Dawaa Medical Services is trading at a P/E lower than the market. Apparently some shareholders are doubtful of the forecasts and have been accepting lower selling prices.

The Bottom Line On Al-Dawaa Medical Services' P/E

Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

Our examination of Al-Dawaa Medical Services' analyst forecasts revealed that its market-matching earnings outlook isn't contributing to its P/E as much as we would have predicted. There could be some unobserved threats to earnings preventing the P/E ratio from matching the outlook. At least the risk of a price drop looks to be subdued, but investors seem to think future earnings could see some volatility.

We don't want to rain on the parade too much, but we did also find 2 warning signs for Al-Dawaa Medical Services that you need to be mindful of.

It's important to make sure you look for a great company, not just the first idea you come across. So take a peek at this free list of interesting companies with strong recent earnings growth (and a low P/E).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.